ARTICLE | Clinical News
Bempedoic acid regulatory update
July 13, 2015 7:00 AM UTC
Esperion said FDA lifted a 2012 partial clinical hold of hypercholesterolemia candidate ETC-1002, which had prevented the company from conducting clinical trials at doses above 240 mg. The company pla...